As a host of generics circle the gates, Novartis has lost another bid to waylay MSN Pharmaceuticals’ copycat of the Swiss ...

The U.S. Centers for Medicare & Medicaid Services (CMS) has released a preliminary list of 101 generic drugs that would be ...

Pharmacists can continue making compounded versions of generic tirzepatide, the active ingredient in popular medications ...

Facing a lawsuit, the Food and Drug Administration has decided to reconsider its decision to take popular weight-loss and diabetes drugs off of the national shortage list, which will allow compounding ...

Participation in the model would be voluntary for Part D sponsors and, pending further development, could start as early as January 2027.

The U.S. Department of Health and Human Services (HHS), through the Centers for Medicare & Medicaid Services (CMS), has taken ...

In June, we heard what could be this year's biggest HIV breakthrough: a twice-yearly injection can prevent HIV infection. Findings from a second large study of the jab has now confirmed that it works.

An initial list of 101 generic drugs available to those enrolled in the government's Medicare program for no more than $2 for ...

Individuals enrolled in Medicare could soon pay just $2 for their prescription medication. The U.S. Centers for Medicare & ...

Last week, the FDA updated its database of drugs in shortage to remove tirzepatide, which had sat on that list – along with related semaglutide ... it's not regulated by the FDA the way branded and ...

CMS released a preliminary list of 101 generic drugs for its Medicare $2 Drug List Model, which aims to cap out-of-pocket ...